PARP inhibitor Olaparib overcomes Sorafenib resistance through reshaping the pluripotent transcriptome in hepatocellular carcinoma

Overview of attention for article published in Molecular Cancer, January 2021

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter: 2 X users

Readers on

mendeley: 20 Mendeley

Summary X

So far, Altmetric has seen 3 X posts from 2 X users, with an upper bound of 2,253 followers.

Putative ligand binding sites of two functionally characterized bark beetle odorant receptors... https://t.co/lghqG1QQw2

29 Jan 2021

Reply Repost Favourite

Happy to have been part of this study. Congrats to Liu Ming and XY Guan for this interesting piece of work! PARP inhibitor olaparib overcomes sorafenib resistance through reshaping the pluripotent transcriptome in hepatocellular carcinoma. https://t.

27 Jan 2021

Reply Repost Favourite

PARP inhibitor Olaparib overcomes Sorafenib resistance through reshaping the pluripotent tran... https://t.co/lghqG1QQw2

26 Jan 2021

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.